Skip to content

Solid Biosciences Inc. SLDB Short-Term Investments

Short-Term Investments at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$188.74M-33.0%
Biogen logo
BiogenBIIB
$900M
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$1.05B+40.1%
Insmed logo
InsmedINSM
$641.33M-19.5%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$219.05M+6.7%
uniQure logo
uniQureQURE
$446.56M+133%

Other financials

Income statement

See full
Revenue$2.0M-40.6%
Operating income-$57.3M-43.1%
Net income-$56.7M-44.4%
EPS (diluted)-$0.52+11.9%

Balance sheet

See full
Cash & equivalents$297.1M+41.1%
Total debt$20.7M-12.5%
Total equity$374.1M+27.1%
Total assets$422.9M+23.0%

Cash flow

See full
Operating cash flow-$47.2M-48.3%
CapEx$165.0K+31.0%
Free cash flow-$47.4M-48.2%

Valuation

See full
Market cap$910.66M+135%
Enterprise value$634.23M+223%
P/S112.5×-10.3×

Profitability

See full
Operating margin-1,315.2%-4,060pp
Net margin-1,062.3%-251,151pp
FCF margin-1,247.7%-9,569pp

Returns & leverage

See full
Return on equity-57.4%+2.2pp
Debt / equity0.1×0.0×
Current ratio13.1×+2.2×

Where this comes from

Reported directly by Solid Biosciences Inc. in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.

The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solid Biosciences Inc.'s short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Solid Biosciences Inc.'s short-term investments?
Solid Biosciences Inc. (SLDB) reported short-term investments of $83.58M in Q1 2026.
How has Solid Biosciences Inc.'s short-term investments changed year-over-year?
Solid Biosciences Inc.'s short-term investments decreased by 13.2% year-over-year, from $96.29M to $83.58M.
What is the long-term trend for Solid Biosciences Inc.'s short-term investments?
Over 4 years (2021 to 2025), Solid Biosciences Inc.'s short-term investments has grown at a 9.6% compound annual growth rate (CAGR), from $88.64M to $127.95M.
What does short-term investments mean?
Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.